2000 Documentation/Coding Stroke 
EB Medicine
AUGUST 6, 2019
Nachi: Specifically, we’ll be focusing on the use of DOACs for the indications of stroke prevention in atrial fibrillation and the treatment and prevention of recurrent venous thromboembolisms. Jeff: Rivaroxaban, trade name Xarelto, the second FDA approved DOAC, is used for stroke prevention in those with nonvalvular afib and VTE treatment.
ACEP Now
OCTOBER 3, 2023
This document is an update of guidelines first published in 2000, and then updated in 2007. Confounders to the GCS such as seizure and post-ictal phase, ingestions and drug overdose, as well as medications administered in the prehospital setting that impact GCS score should be documented. 2019;154(7):e191152.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pediatric Emergency Playbook
JUNE 1, 2017
The best documented cormorbidity is sickle cell disease, although other pro-thrombotic conditions also put the child at risk. The previously well child now decompensated: undiagnosed thrombophilia Asymptomatic patent foramen ovale (PFO) is the cause of some cases of cryptogenic vascular disease, such as stroke and MI. Pongratz G et al.
Sensible Medicine
FEBRUARY 28, 2024
JMM Although the skeptical cardiologist questions the value of many procedures and diagnostic tests in cardiology, he remains an enthusiastic advocate of the use of coronary artery calcium (CAC) testing to better personalize each individual's risk of heart attack and stroke. For many individuals, this is life-transforming.
Dr. Smith's ECG Blog
APRIL 8, 2015
Thus, if there is documented sinus bradycardia, and no suspicion of high grade AV block, at the time of the syncope, this is very useful. Syncope and cause of death were identified by codes from the International Classification of Disease, Ninth Revision. to 1.45) for fatal or nonfatal stroke. g/dL Hypotension (obviously!)
Expert insights. Personalized for you.
40 
Let's personalize your content